Skip to content

Clinical trials

Tardive Dyskinesia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tardive Dyskinesia Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20033
20063
20083
20091
20101
20114
20123
20133
20145
20154
20162
20175
20182
20192
20221
20233
20242
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Unknown status7
Recruiting6
Withdrawn6
Terminated3
Not yet recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Neurocrine Biosciences13
Luye Pharma Group Ltd.4
Auspex Pharmaceuticals, Inc.3
Beersheva Mental Health Center2
Beijing HuiLongGuan Hospital2
Emory University2
Shanghai Mental Health Center2
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan2
Yale University2
Caroff, Stanley N., M.D.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tardive Dyskinesia61
Schizophrenia17
Movement Disorders10
Psychotic Disorders7
Dyskinesias6
Huntington Disease4
Neurologic Manifestations4
Signs and Symptoms4
Central Nervous System Diseases3
Intellectual Disability3

Trials

Showing 26 to 50 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.